Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Ewiwi
    Junior Member
    • Jun 2017
    • 3

    #1

    BAM file size difference between 2 sequencing platforms

    Hello everyone,

    It is my first time posting so I don't really know if I'm at the right place.
    I am new to sequencing and still a student so please tell me if my question is a dumb question:

    I'm working on a project in which we have sequencing datas of people coming from 2 platforms: one from Thermofischer and one from Illumina. However, the BAM file size per individual is 8 times bigger for the Thermofischer originated datas compared to the Illumina datas. How can that be explained ? Can it be the sequencing method (Sanger/ Ion torrent for Thermofischer), the coverage, or the alignment software used ? (For Illumina dataset, the iSAAC pipeline was used apparently).

    I really want to get a better understanding of all these things so if you have advices or documents that might help me, I'll be happy to take it.

    Thank you very much!!!
    Last edited by Ewiwi; 06-26-2017, 07:19 PM.
  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    Originally posted by Ewiwi View Post
    I'm working on a project in which we have sequencing datas of people coming from 2 platforms: one from Thermofischer and one from Illumina. However, the BAM file size per individual is 8 times bigger for the Thermofischer originated datas compared to the Illumina datas. How can that be explained ? Can it be the sequencing method (Sanger/ Ion torrent for Thermofischer), the coverage, or the alignment software used ?
    Yes, it could be any of those! Normally a bam file's size is most closely related to the coverage, but the contents can vary considerably based on all of those factors - some aligners produce multiple lines per read, and add a bunch of optional fields to each line. The bam generation settings also have a large impact - the file could be compressed or uncompressed, sorted or unsorted. And different platforms produce very different quality score profiles; much of the size of a compressed bam comes from the quality scores.

    Comment

    • Ewiwi
      Junior Member
      • Jun 2017
      • 3

      #3
      Thank you very much for your reply. I start to understand better how are generated BAM files now. So I guess that these different datasets can't really be compared in downstream applications even if they were aligned on the same reference genome? Since the alignment methods may differ (and I'm almost sure they are) can I really compare them in the end ?

      Thank you for helping a poor student

      Comment

      • Brian Bushnell
        Super Moderator
        • Jan 2014
        • 2709

        #4
        You can usually compare data qualitatively if it was aligned by the same version of the same aligner, using the same reference.

        You cannot usefully compare data quantitatively if:

        1) The aligner was different.
        2) The reference was different.
        3) The platform was different.
        4) The preprocessing was different.
        5) The lysing was different.
        6) The amplification was different.
        7) The DNA quantity or concentration was different.
        8) Anything was different, other than the sample.

        You can usefully compare things if a single variable differs, for the purposes of evaluating the single variable's effect on results. It is pointless to compare things when there are many differences in methodology, unless you are following something like a rigorous fractional factorial design, which requires design prior to experimentation.

        Comment

        • Ewiwi
          Junior Member
          • Jun 2017
          • 3

          #5
          Thank you very much for your quick reply. I'll keep that in mind !

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 10-22-2026, 11:13 AM
          0 responses
          26 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-22-2026, 10:48 AM
          0 responses
          20 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          36 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          43 views
          0 reactions
          Last Post SEQadmin2  
          Working...